Concentrations of Ag, Al, Au, Bi, Cd, Cu, Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasms.

1984 ◽  
Vol 30 (8) ◽  
pp. 1358-1360 ◽  
Author(s):  
A El-Yazigi ◽  
I Al-Saleh ◽  
O Al-Mefty
Keyword(s):  
Cerebrospinal Fluid ◽  
Brain Tumors ◽  
Benign Tumor ◽  
Atomic Absorption Spectrophotometry ◽  
Control Group ◽  
Tumor Control ◽  
Tumor Patients ◽  
Absorption Spectrophotometry ◽  
The Mean ◽  
Cerebral Neoplasms

Abstract We measured the concentrations of nine trace elements in cerebrospinal fluid of 11 patients with malignant brain tumors, 11 with benign brain tumors, and 10 control patients, using flameless atomic absorption spectrophotometry. The mean and standard deviation for these concentrations (microgram/L) in the control group were 5.1 +/- 2.9 (silver), 326.6 +/- 171.2 (aluminum), 38.5 +/- 32.2 (gold), 36.6 +/- 23.7 (bismuth), 1.5 +/- 1.3 (cadmium), 39.8 +/- 24.7 (copper), 15.7 +/- 11.5 (lead), 20.9 +/- 3.8 (antimony), and 19.1 +/- 13.3 (selenium). Concentrations of silver and lead were markedly increased in patients with malignant cerebral neoplasms. The malignant-tumor/control patient concentration ratios were 2.31 for silver and 2.11 for lead. We observed no significant differences between the results for the benign tumor patients and the control group.

Concentrations of zinc, iron, molybdenum, arsenic, and lithium in cerebrospinal fluid of patients with brain tumors.

1986 ◽  
Vol 32 (12) ◽  
pp. 2187-2190 ◽  
Author(s):  
A el-Yazigi ◽  
I Al-Saleh ◽  
O Al-Mefty
Keyword(s):  
Cerebrospinal Fluid ◽  
Brain Tumors ◽  
Malignant Tumors ◽  
Atomic Absorption Spectrophotometry ◽  
Control Group ◽  
Neoplastic Disease ◽  
Tumor Patients ◽  
Absorption Spectrophotometry ◽  
And Control ◽  
Csf Concentration

Abstract We used flameless atomic absorption spectrophotometry to measure concentrations of Fe, Mo, Li, As, and Zn in cerebrospinal fluid (CSF) of patients with malignant brain tumors benign brain tumors, non-brain malignant tumors and control (non-neoplastic disease) patients. Mean (and SD) concentrations (microgram/L) of these elements in the control group were 62.7 (28.7) for Fe, 6.8 (4.8) for Mo, 0.7 (2.0) for Li, 1.3 (0.7) for As, 7 (5.9) for Zn. We could detect Li in less than 53% of controls. Zn concentrations in CSF of patients with astrocytoma (malignant brain tumor), benign brain tumors, or non-brain tumors were significantly (p less than 0.05) less than in control patients; the ratios for mean concentrations of Zn in tumor patients/control patients for the above groups were 0.3, 0.20, and 0.17, respectively. Concentrations of As in CSF of patients with non-brain malignant tumors were significantly (p less than 0.05) higher than in the controls; the ratio for mean CSF concentration of As in patients with non-brain tumors/control patients was 2.9. Differences in the concentrations of Fe, Li, or Mo among the various groups were nonsignificant.

Concentrations of chromium, cesium, and tin in cerebrospinal fluid of patients with brain neoplasms, leukemia or other noncerebral malignancies, and neurological diseases.

1988 ◽  
Vol 34 (6) ◽  
pp. 1084-1086 ◽  
Author(s):  
A el-Yazigi ◽  
C R Martin ◽  
E B Siqueira
Keyword(s):  
Cerebrospinal Fluid ◽  
Brain Tumors ◽  
Brain Neoplasms ◽  
Neurological Disorders ◽  
Neurological Diseases ◽  
Atomic Absorption Spectrophotometry ◽  
Control Group ◽  
Absorption Spectrophotometry ◽  
The Mean ◽  
Csf Concentration

Abstract We measured the concentrations of chromium, cesium, and tin in the cerebrospinal fluid (CSF) of 29 patients with brain tumors [21 benign (BBT) and eight malignant (MBT)], 28 leukemic patients, 14 patients with lymphoma or noncerebral solid tumors (NLCT), and 32 control patients (15 with neurological disorders and 17 with noneurological conditions) by use of flameless atomic absorption spectrophotometry. We detected chromium in 94% of the patients, tin in 79%, and cesium in 50%. The mean (and SEM) concentrations (micrograms/L) of these metals in the control group were 4.7 (1.1) for chromium, 3.8 (1.6) for cesium, and 6.4 (1) for tin. We observed significant differences (P less than 0.05) in the concentration of chromium in CSF between the MBT group and all other tumor groups; the ratios for the mean CSF concentration of chromium in patients with BBT, leukemia, or NLCT to that in patients with MBT were 2.6, 2.1, or 4.4, respectively. We saw no significant differences in the concentrations of cesium or tin among the various groups investigated.

Optimized atomic absorption spectrophotometry of zinc in cerebrospinal fluid.

1983 ◽  
Vol 29 (3) ◽  
pp. 486-491 ◽  
Author(s):  
R Palm ◽  
R Sjöström ◽  
G Hallmans
Keyword(s):  
Cerebrospinal Fluid ◽  
Atomic Absorption ◽  
Direct Determination ◽  
Atomic Absorption Spectrophotometry ◽  
Absorption Spectrophotometry ◽  
Flame Atomic Absorption ◽  
Zn Concentration ◽  
Insignificant Difference ◽  
The Mean

Abstract This method for direct determination of Zn in cerebrospinal fluid (CSF) involves flame atomic absorption spectrophotometry with a pulse nebulizer technique. Standard solutions of Zn in 150 mmol/L NaCl were used. We could account for 88% of added standard with the method in individual samples from 10 patients and in pooled CSF. The method is acceptably precise, CVs in pooled CSF ranging from 4 to 12%. The mean CSF-Zn concentration for nine healthy men was 0.18 (SD 0.04) mumol/L and for nine healthy women 0.15 (SD 0.03) mumol/L, a statistically insignificant difference. These values are lower than those in previous reports, which may have been the result of contamination problems, nonatomic absorption, or nonstandardized sampling. In the healthy volunteers, the CSF-Zn concentration was positively correlated with serum-Zn, CSF-protein, and CSF-albumin concentrations, as well as with the CSF/serum ratio for albumin.

Interlaboratory Study of Blood Selenium Determinations

1987 ◽  
Vol 70 (4) ◽  
pp. 664-667
Author(s):  
Tee-Siaw Koh
Keyword(s):  
Hydride Generation ◽  
Atomic Absorption Spectrophotometry ◽  
Bovine Blood ◽  
Blood Samples ◽  
X Ray ◽  
Absorption Spectrophotometry ◽  
Coefficients Of Variation ◽  
The Mean ◽  
Se Deficiency

Abstract Fifty-one laboratories from 14 countries participated in a survey on the determination of selenium (Se) in 8 bovine blood samples with Se concentrations ranging from 0.2 μmol/L (0.016 μg/mL) to 14 μmol/L (1.1 μg/mL). The methods used (and the percentage of participants using each method) were fiuorometry (61), hydride-generation atomic absorption spectrophotometry (AAS) (23), graphitefurnace AAS (6), gas chromatography (4), neutron activation analysis (4), and X-ray fiuorometry (2). There was little difference in the mean Se results obtained by fiuorometry or hydride-generation AAS (P > 0.05). Mean intralaboratory coefficients of variation (CVs) from known replicates ranged from 4 to 14% for all samples. Interlaboratory CVs were related to blood Se concentration and increased to 55% at Se levels below 0.4 μmol/L (0.032 μg/mL). Laboratories that used quality control (QC) schemes had lower interlaboratory CVs than those that did not, but the advantage began to diminish at blood Se concentration below 0.4 μmol/L (0.032 μg/mL). The high interlaboratory CVs, coupled with the false assurance from the low intralaboratory CVs and the ineffectiveness of the QC schemes at blood Se concentrations below 0.4 μmol/L (0.032 μg/mL), are of concern in diagnosis of marginal Se deficiency in livestock where the concentrations of interest are in the range 0.15-0.5 μmol/L (0.012-0.039 μg/mL).

Optimized atomic absorption spectrophotometry of calcium in erythrocytes.

1987 ◽  
Vol 33 (11) ◽  
pp. 2004-2007 ◽  
Author(s):  
S Nomoto ◽  
S Shoji
Keyword(s):  
Hydrochloric Acid ◽  
Atomic Absorption ◽  
Atomic Absorption Spectrophotometry ◽  
Graphite Tube ◽  
Optimum Conditions ◽  
Absorption Spectrophotometry ◽  
Flame Atomic Absorption ◽  
Flame Atomic Absorption Spectrophotometer ◽  
The Mean ◽  
Mean Concentration

Abstract We sought to establish optimum conditions for measuring calcium in erythrocytes by atomic absorption spectrophotometry. The conditions we selected are as follows. Wash one volume of fresh heparin-treated packed cells once with 30 volumes of isotonic buffered saline (pH 7.4) at a temperature somewhat exceeding 25 degrees C. Dilute the washed packed cells 10-fold with 12 mmol/L hydrochloric acid, and analyze the supernate for calcium. Measure the hematocrit of the washed packed cells, then analyze an aliquot of them for calcium, using a computer-readout type of flame or a non-flame atomic absorption spectrophotometer equipped with a pyrocoated graphite tube. The temperature program is 1000 degrees C for ashing [corrected] and 1800 degrees C for the atomizing cycle. Intraday and day-to-day reproducibility of the assay was 6.55% and 8.19%, respectively, at the mean concentration of calcium in the erythrocytes of healthy adults, which is 4.30 mumol/L.

scholarly journals Cadmium, Copper, Lead, and Zinc Contents of Fish Marketed in NW Mexico

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Martín G. Frías-Espericueta ◽  
Francia K. G. Zamora-Sarabia ◽  
J. Isidro Osuna-López ◽  
María D. Muy-Rangel ◽  
Werner Rubio-Carrasco ◽  
...  
Keyword(s):  
Dry Weight ◽  
Fish Muscle ◽  
Atomic Absorption Spectrophotometry ◽  
Human Consumption ◽  
Fish Muscles ◽  
Absorption Spectrophotometry ◽  
Nw Mexico ◽  
Lead And Zinc ◽  
The Mean ◽  
Copper Lead

To assess if they were within the safety limits for human consumption, the Cd, Cu, Pb, and Zn contents of fish muscles, bought from separate stalls of the fish markets of nine cities of NW Mexico, were determined by atomic absorption spectrophotometry. Considering all fish and markets, the mean contents were Zn:23.23±5.83, Cu:1.72±0.63, Cd:0.27±0.07, and Pb:0.09±0.04 µg/g (dry weight). Cu, Zn, and Pb did not reach levels of concern for human consumption, but the high Cd values determined in Mazatlán (Mugil cephalus:0.48±0.15;Diapterusspp.:0.57±0.33;Lutjanusspp.:0.72±0.12; small shark:0.87±0.19 µg/g dry weight) indicate that this was the only metal of concern for human health because the daily individual consumption of fish muscle to reach the PTDI would be within 0.27 and 0.41 kg.

scholarly journals Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors

Cancers ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 1546 ◽  
Author(s):  
Alena Kopkova ◽  
Jiri Sana ◽  
Tana Machackova ◽  
Marek Vecera ◽  
Lenka Radova ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Brain Tumor ◽  
Brain Tumors ◽  
Low Grade ◽  
Tumor Type ◽  
Tumor Patients ◽  
Primary Tumors ◽  
Mirna Profiling ◽  
Tumor Types ◽  
Cns Malignancies

Central nervous system (CNS) malignancies include primary tumors that originate within the CNS as well as secondary tumors that develop as a result of metastatic spread. Circulating microRNAs (miRNAs) were found in almost all human body fluids including cerebrospinal fluid (CSF), and they seem to be highly stable and resistant to even extreme conditions. The overall aim of our study was to identify specific CSF miRNA patterns that could differentiate among brain tumors. These new biomarkers could potentially aid borderline or uncertain imaging results onto diagnosis of CNS malignancies, avoiding most invasive procedures such as stereotactic biopsy or biopsy. In total, 175 brain tumor patients (glioblastomas, low-grade gliomas, meningiomas and brain metastases), and 40 non-tumor patients with hydrocephalus as controls were included in this prospective monocentric study. Firstly, we performed high-throughput miRNA profiling (Illumina small RNA sequencing) on a discovery cohort of 70 patients and 19 controls and identified specific miRNA signatures of all brain tumor types tested. Secondly, validation of 9 candidate miRNAs was carried out on an independent cohort of 105 brain tumor patients and 21 controls using qRT-PCR. Based on the successful results of validation and various combination patterns of only 5 miRNA levels (miR-30e, miR-140, let-7b, mR-10a and miR-21-3p) we proposed CSF-diagnostic scores for each tumor type which enabled to distinguish them from healthy donors and other tumor types tested. In addition to this primary diagnostic tool, we described the prognostic potential of the combination of miR-10b and miR-196b levels in CSF of glioblastoma patients. In conclusion, we performed the largest study so far focused on CSF miRNA profiling in patients with brain tumors, and we believe that this new class of biomarkers have a strong potential as a diagnostic and prognostic tool in these patients.

MEASUREMENT OF CALCIUM OF MILK BY ATOMIC ABSORPTION SPECTROPHOTOMETRY IN THE PRESENCE OF MAJOR INGREDIENTS OF DETERGENTS1,2

1973 ◽  
Vol 36 (11) ◽  
pp. 554-558 ◽  
Author(s):  
M. E. Anderson ◽  
D. B. Brooker ◽  
J. R. Fischer ◽  
E. L. Ruiz ◽  
R. T. Marshall
Keyword(s):  
Statistical Analysis ◽  
Phosphoric Acid ◽  
Atomic Absorption ◽  
Contact Surface ◽  
Practical Importance ◽  
Sodium Metasilicate ◽  
Atomic Absorption Spectrophotometry ◽  
Sodium Gluconate ◽  
Absorption Spectrophotometry ◽  
The Mean

Twelve chemical ingredients commonly used to formulate detergents were tested to determine their interferences with measurement of calcium in milk by atomic absorption spectrophotometry. For concentrations of 0.01, 0.1, and 1.0% milk, the mean amounts of calcium measured for all ingredients were 0.20, 1.85, and 15.89 mg/1, respectively. Statistical analysis showed that milk accounted for 97.3% of the variation in spectrophotometric response with temperature and concentration of ingredient being of little practical importance. However, increasing the temperature caused the instrument to indicate increased amounts of calcium in solutions containing sodium metasilicate (anhydrous), EDTA plus sodium hydroxide, sodium gluconate, and phosphoric acid. Changing the concentration of ingredient did not interfere substantially with the amount of calcium measured except for sodium metasilicate (anhydrous) where an increase in concentration reduced the amount of calcium measured. From the data it can be concluded that an atomic absorption spectrophotometer shows considerable promise for use in monitoring removal of residue from a milk contact surface.

scholarly journals Study Protocol for a Randomized Controlled Trial Evaluating the Efficacy of an Evidence-Based iPad-App for Cognitive Rehabilitation in Patients with Primary Brain Tumors

Neurosurgery ◽  
2018 ◽  
Vol 85 (2) ◽  
pp. 273-279 ◽  
Author(s):  
Sophie Dorothee van der Linden ◽  
Margriet Maria Sitskoorn ◽  
Geert-Jan Maria Rutten ◽  
Karin Gehring
Keyword(s):  
Randomized Controlled Trial ◽  
Brain Tumor ◽  
Brain Tumors ◽  
Cognitive Rehabilitation ◽  
Controlled Trial ◽  
Rehabilitation Program ◽  
Control Group ◽  
Tumor Patients ◽  
Primary Brain Tumors ◽  
Randomized Controlled

Abstract BACKGROUND Many patients with primary brain tumors suffer from cognitive deficits, which negatively impact their quality of life. However, cognitive rehabilitation programs for these patients are scarce. We developed an iPad-based cognitive rehabilitation program for brain tumor patients, which was based on our effective face-to-face cognitive rehabilitation program. After successful completion of a feasibility study, a randomized controlled trial has been started. OBJECTIVE To evaluate the immediate and long-term effects of the iPad-based program on cognitive performance and patient-reported outcome measures (PROMs) in patients with primary brain tumors in an early stage of the disease. METHODS Prior to surgery, patients with presumed low-grade glioma and meningioma are included. Before surgery and 3 mo after surgery, neuropsychological assessments are conducted. After the second neuropsychological assessment, patients are assigned to the intervention group or waiting-list control group. The intervention consists of psychoeducation, compensation training, and retraining. Patients are advised to spend 3 h per week on the program for 10 wk. Immediately after completion of the program and a half-year thereafter, postintervention assessments take place. Patients in the control group are offered the opportunity to follow the program after all study assessments. EXPECTED OUTCOMES We expect that early cognitive rehabilitation has beneficial effects on cognitive performance and PROMs in brain tumor patients. DISCUSSION The iPad-based program allows brain tumor patients to follow a cognitive rehabilitation program from their homes. Forthcoming results may contribute to further improvement of supportive care for brain tumor patients.

Plasma Cadmium and Zinc in Human Hypertension

1976 ◽  
Vol 51 (5) ◽  
pp. 483-486 ◽  
Author(s):  
G. S. Thind ◽  
Grace M. Fischer
Keyword(s):  
Significant Positive Correlation ◽  
Venous Blood ◽  
Normal Subjects ◽  
Atomic Absorption Spectrophotometry ◽  
Hypertensive Patients ◽  
Peripheral Venous Blood ◽  
Absorption Spectrophotometry ◽  
Arterial Blood ◽  
The Mean ◽  
Cadmium Zinc

1. Plasma cadmium and zinc were determined by atomic absorption spectrophotometry in inferior venal caval or peripheral venous blood in thirty hypertensive patients and fifteen normal subjects. 2. The mean plasma cadmium in hypertensive patients was significantly higher than in normal control subjects. 3. The plasma cadmium/zinc ratio was significantly greater in hypertensive patients. 4. There was a significant positive correlation between the plasma cadmium/zinc ratio and the mean arterial blood pressure.

Sign in / Sign up

Export Citation Format

Share Document